Malignant Fallopian Tube Neoplasm — Trials

Malignant Fallopian Tube Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

744 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 168
Recruiting: 76
Ph III recruiting: 12
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00753480	A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	suspended	Phase 1	56	Genentech, Inc.INDUSTRY	1	Nov 7, 2008	clinicaltrials

Data updated 22 days agoSource updated Nov 7, 2008source: clinicaltrials